HIF-1α in heart: Protective mechanisms

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 305, Issue 6, 2013, Pages

  Wu, Joe ^a   Chen, Ping ^a   Li, Ying ^a   Ardell, Chris ^a   Der, Tatyana ^a   Shohet, Ralph ^b   Chen, Minghua ^a   Wright, Gary L ^a  

^a East Tennessee State University   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

Cardioprotection; Hibernation; Mitochondrial and metabolism

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYANIDE; DEOXYGLUCOSE; GLYCOGEN; GLYCOGEN SYNTHASE; GLYCOLYTIC ENZYME; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; GLUCOSE TRANSPORT; GLYCOGEN ANALYSIS; GLYCOGEN METABOLISM; GLYCOLYSIS; HEART; HEART DEPOLARIZATION; HEART HOMOGENATE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOGENATE; HYPOXIA; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; VOLKMANN CONTRACTURE; WESTERN BLOTTING;

CARDIOPROTECTION; HIBERNATION; MITOCHONDRIAL AND METABOLISM;

ANIMALS; BLOOD PRESSURE; CARDIOTONIC AGENTS; GLYCOGEN; GLYCOLYSIS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, TRANSGENIC; OXYGEN; RECOVERY OF FUNCTION; REPERFUSION INJURY;

EID: 84884374433     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00140.2013     Document Type: Article

References (31)

1. Bekeredjian R, Walton CB, MacCannell KA, Ecker J, Kruse F, Outten JT, Sutcliffe D, Gerard RD, Bruick RK, Shohet RV. Conditional HIF-1alpha expression produces a reversible cardiomyopathy. PLoS One 5: e11693, 2010.
2. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294: 1337-1340, 2001.
3. Cai Z, Zhong H, Bosch-Marce M, Fox-Talbot K, Wang L, Wei C, Trush MA, Semenza GL. Complete loss of ischaemic preconditioninginduced cardioprotection in mice with partial deficiency of HIF-1 alpha. Cardiovasc Res 77: 463-470, 2008.
4. Cross HR, Opie LH, Radda GK, Clarke K. Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved. Circ Res 78: 482-491, 1996.
5. Cummins EP, Berra E, Comerford KM, Ginouves A, Fitzgerald KT, Seeballuck F, Godson C, Nielsen JE, Moynagh P, Pouyssegur J, Taylor CT. Prolyl hydroxylase-1 negatively regulates IκB kinase-beta, giving insight into hypoxia-induced NFκB activity. Proc Natl Acad Sci USA 103: 18154-18159, 2006.
6. Eckle T, Kohler D, Lehmann R, El KK, Eltzschig HK. Hypoxiainducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 118: 166-175, 2008.
7. Giannattasio S, Gagliardi S, Samaja M, Marra E. Simultaneous determination of purine nucleotides, their metabolites and beta-nicotinamide adenine dinucleotide in cerebellar granule cells by ion-pair high performance liquid chromatography. Brain Res 10: 168-174, 2003.
8. Hearse DJ, Garlick PB, Humphrey SM. Ischemic contracture of the myocardium: mechanisms and prevention. Am J Cardiol 39: 986-993, 1977.
9. Heusch G, Schulz R. Myocardial hibernation. Ital Heart J 3: 282-284, 2002.
10. Hewitson KS, McNeill LA, Riordan MV, Tian YM, Bullock AN, Welford RW, Elkins JM, Oldham NJ, Bhattacharya S, Gleadle JM, Ratcliffe PJ, Pugh CW, Schofield CJ. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem 277: 26351-26355, 2002.
11. Hochachka PW. Molecular mechanisms of defense against oxygen lack. Undersea Biomed Res 16: 375-379, 1989.
12. Hochachka PW, Dunn JF. Metabolic arrest: the most effective means of protecting tissues against hypoxia. Prog Clin Biol Res 136: 297-309, 1983.
13. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16: 1466-1471, 2002.
14. Miller A, Wright GL. Fabrication of murine ventricular balloons for the langendorff heart preparation. J Biotechnol Biomater 1: 2011.
15. Minchenko A, Leshchinsky I, Opentanova I, Sang N, Srinivas V, Armstead V, Caro J. Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem 277: 6183-6187, 2002.
16. Natarajan R, Salloum FN, Fisher BJ, Kukreja RC, Fowler AA, III. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ Res 98: 133-140, 2006.
17. Natarajan R, Salloum FN, Fisher BJ, Ownby ED, Kukreja RC, Fowler AA, III. Activation of hypoxia-inducible factor-1 via prolyl-4 hydoxylase-2 gene silencing attenuates acute inflammatory responses in postischemic myocardium. Am J Physiol Heart Circ Physiol 293: H1571-H1580, 2007.
18. O'Connell TD, Rodrigo MC, Simpson PC. Isolation and culture of adult mouse cardiac myocytes. Methods Mol Biol 357: 271-296, 2007.
19. Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, Fowler AA, III, Kukreja RC. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Am J Physiol Heart Circ Physiol 289: H542-H548, 2005.
20. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3: 187-197, 2006.
21. Pescador N, Villar D, Cifuentes D, Garcia-Rocha M, Ortiz-Barahona A, Vazquez S, Ordonez A, Cuevas Y, Saez-Morales D, Garcia-Bermejo ML, Landazuri MO, Guinovart J, Del PL. Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1. PLoS One 5: e9644, 2010.
22. Philipp S, Cui L, Ludolph B, Kelm M, Schulz R, Cohen MV, Downey JM. Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS. Am J Physiol Heart Circ Physiol 290: H450-H457, 2006.
23. Semenza GL. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem Pharmacol 59: 47-53, 2000.
24. Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7: 345-350, 2001.
25. Semenza GL. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 19: 176-182, 2004.
26. Semenza GL, Koury ST, Nejfelt MK, Gearhart JD, Antonarakis SE. Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc Natl Acad Sci USA 88: 8725-8729, 1991.
27. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12: 5447-5454, 1992.
28. Sridharan V, Guichard J, Bailey RM, Kasiganesan H, Beeson C, Wright GL. The prolyl hydroxylase oxygen-sensing pathway is cytoprotective and allows maintenance of mitochondrial membrane potential during metabolic inhibition. Am J Physiol Cell Physiol 292: C719-C728, 2007.
29. 2 respiration, reduced ATP utilization, and inducible fumarate respiration. Am J Physiol Cell Physiol 295: C29-C37, 2008.
30. 2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
31. Wright G, Higgin JJ, Raines RT, Steenbergen C, Murphy E. Activation of the prolyl hydroxylase oxygen-sensor results in induction of GLUT1, heme oxygenase-1, and nitric-oxide synthase proteins and confers protection from metabolic inhibition to cardiomyocytes. J Biol Chem 278: 20235-20239, 2003.